BME100 s2015:Group16 12pmL2

From OpenWetWare

Jump to: navigation, search
BME 100 Spring 2015 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help
Image:BME494_Asu_logo.png

Contents

OUR TEAM

Name: Trevaun Walker
Name: Trevaun Walker
Name: Thomas Murphy
Name: Thomas Murphy
Name: Hanna Monroe
Name: Hanna Monroe
Name: Natkanes Pakjirasirikul
Name: Natkanes Pakjirasirikul
Name: Reaghan Fletcher
Name: Reaghan Fletcher

LAB 2 WRITE-UP

Descriptive Statistics

Experiment 1

This was a human based study to see if various doses of LPS (0 mg, 5 mg, 10 mg, and 15 mg) increase the levels of inflammotin in the elderly at a retirement center.


Image:Data table 1.jpg


Experiment 2

This was a rat based study to see if the LPS treatment increased Inflammotin protein levels

Image:Rate_table.jpg



Results

Experiment 1

Image:Graph Data 1.jpg


Image:Data Table 2.jpg


Experiment 2

Image:RatGraph.jpg


Image:Rat_ANOVA.jpg




Analysis

Experiment 1


Image:Data 3.jpg

Experiment 2
Image:PostHocTest2.png




Summary/Discussion

Based on the p-value for experiment 1, there is a statistically significant difference among the different doses of LPS. Upon further analysis between all groups, each comparison showed significance when comparing the t-test values to the corrected p-value. In this study of inflammotin and the elderly, we found that the dose of LPS does make a difference in the amount of inflammotin in elderly. However, in experiment 2, there was no significant difference between the doses of LPS. The dose of LPS does not make a significant difference in the amount of inflammotin.

Personal tools